PropertyValue
?:abstract
  • To facilitate containment of the COVID-19 pandemic currently active in the United States and across the world, options for easy, non-invasive antibody testing are required. Here we have adapted a commercially available, serum-based enzyme-linked immunosorbent assay (ELISA) for use with saliva samples, achieving 84.2% sensitivity and 100% specificity in a set of 149 clinical samples. This strategy will enable widespread, affordable testing for patients who experienced this disease, whilst minimizing exposure risk for healthcare workers.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1038/s41598-020-77555-4
?:journal
  • Sci_Rep
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/2bcf587ec16622876795bc6292c9abcf63c3c2bb.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7705674.xml.json
?:pmcid
?:pmid
?:pmid
  • 33257702.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • ELISA detection of SARS-CoV-2 antibodies in saliva
?:type
?:year
  • 2020-11-30

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ckjzr31j>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ckjzr31j>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all